Literature DB >> 9389990

Acromegaly: the significance of serum total and free IGF-I and IGF-binding protein-3 in diagnosis.

A J van der Lely1, W W de Herder, J A Janssen, S W Lamberts.   

Abstract

We have studied the physiological and clinical relevance of measurements of serum total and free IGF-I and IGF-binding protein-3 (IGFBP-3) in 57 previously untreated patients with active acromegaly (32 males, 25 females; mean age 47 years) as compared with sex- and age-matched normal healthy controls. Serum total and free IGF-I, but not IGFBP-3, are suitable biochemical parameters for screening for acromegaly. In acromegalics, the mean 24 h serum GH, total IGF-I and IGFBP-3 levels tend to decrease with age. However, in our series of patients, mean 24 h serum GH levels, IGFBP-3, total and free IGF-I do not correlate with disease activity in acromegaly.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9389990

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  3 in total

1.  Is the measurement of free IGF-I more indicative than that of total IGF-I in the evaluation of the biological activity of the GH/IGF-I axis?

Authors:  J A Janssen; S W Lamberts
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

Review 2.  Nanomedicines in the treatment of acromegaly: focus on pegvisomant.

Authors:  Ferdinand Roelfsema; Nienke R Biermasz; Alberto M Pereira; Johannes Romijn
Journal:  Int J Nanomedicine       Date:  2006

Review 3.  Utility of free IGF-I measurements.

Authors:  Jan Frystyk
Journal:  Pituitary       Date:  2007       Impact factor: 3.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.